Kovai Medical Center and Hospital Limited has closed its trading window for dealing in the company's securities, effective July 1, 2026. This restriction applies to insiders, designated persons, and their immediate relatives. The measure is intended to prevent insider trading in line with regulatory norms.

The trading window will remain closed until the end of 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This closure is pursuant to Clause 4 of Schedule B of the SEBI (Prohibition of Insider Trading) Regulations 2015, as amended, and the company's Code of Conduct for Prevention of Insider Trading.

The company has not yet announced the specific date for the board meeting where the unaudited financial results for the quarter will be declared. This information will be intimated in due course.

Kovai Medical Center and Hospital Limited announced the demise of its Joint Managing Director, Dr. Thavamani Devi Palaniswami, on June 6, 2026. The company disclosed this information in a regulatory filing submitted to BSE Limited, marking the end of her tenure as a key leader and promoter. Her passing is considered an irreparable loss to the organization, which benefited significantly from her leadership since she joined the board.

Dr. Thavamani Devi Palaniswami served as a Director of the company effective from July 29, 2000. In compliance with Regulation 31A(6)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, she has ceased to be part of the promoter group of the company following her death. The board and employees have expressed deep condolences to her family.

The filing provided specific details regarding the change in the company's shareholding and leadership structure. The disclosure confirms that the cessation of her role as a director and promoter is effective immediately from the date of her demise. No other directorships in listed entities were held by her at the time of passing.

Details of Cessation